Earnings Feed
Start Free
Home/Filings/4/0001437749-21-028832
4//SEC Filing

Astor Andrew 4

Accession 0001437749-21-028832

CIK 0001196298other
View on SEC.govCompany Profile

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 9:16 PM ET

Size

16.3 KB

Accession

0001437749-21-028832

Insider Transaction Report

Form 4
Period: 2021-12-14
NEPHROS INCNEPH
Astor Andrew
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-12-14+38,612→ 38,612 total
    Exercise: $6.82Exp: 2031-12-14→ Common Stock (38,612 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $2.64Exp: 2027-05-01→ Common Stock (46,525 underlying)
    46,525

  • Stock Option (right to buy)

    Exercise: $5.85Exp: 2028-12-19→ Common Stock (22,223 underlying)
    22,223

  • Stock Option (right to buy)

    Exercise: $4.14Exp: 2027-02-13→ Common Stock (64,399 underlying)
    64,399

  • Stock Option (right to buy)

    Exercise: $8.30Exp: 2029-12-16→ Common Stock (20,000 underlying)
    20,000

  • Warrants (right to buy)

    Exercise: $2.70From: 2017-03-17Exp: 2022-03-17→ Common Stock (14,815 underlying)
    14,815

  • Stock Option (right to buy)

    Exercise: $4.50Exp: 2027-12-20→ Common Stock (5,556 underlying)
    5,556

  • Common Stock

    77,958

  • Stock Option (right to buy)

    Exercise: $7.07Exp: 2030-08-24→ Common Stock (152,064 underlying)
    152,064
Footnotes (7)
  • [F1]On 2/13/17, the Reporting Person was granted an option to purchase 64,399 shares of common stock of the Company. Options to purchase 8,049 shares vested on 2/13/18; options to purchase 24,150 shares vest quarterly in 12 equal amounts commencing on 5/13/18; and options to purchase 32,200 shares vested upon achievement of previously disclosed performance measures.
  • [F2]On 5/1/17, the Reporting Person was granted an option to purchase 46,525 shares of common stock of the Company. Options to purchase 5,815 shares vested on 5/1/18; options to purchase 17,447 shares vest quarterly in 12 equal amounts commencing on 7/1/18; and options to purchase 23,263 shares vested upon achievement of previously disclosed performance measures.
  • [F3]On 12/20/17, the Reporting Person was granted an option to purchase 5,556 shares of common stock of the Company. Options to purchase 1,389 shares vested on 12/20/18 and options to purchase 4,167 shares vest quarterly in 12 equal amounts commencing on 3/20/19.
  • [F4]On 12/19/18, the Reporting Person was granted an option to purchase 22,223 shares of common stock of the Company. Options to purchase 5,555 shares vested on 12/19/19 and options to purchase 16,668 shares vest quarterly in 12 equal amounts commencing on 3/19/20.
  • [F5]On 12/16/19, the Reporting Person was granted an option to purchase 20,000 shares of common stock of the Company. Options to purchase 5,000 shares vest on 12/16/20 and options to purchase 15,000 shares vest quarterly in 12 equal amounts commencing on 3/16/21.
  • [F6]On 8/24/20, the Reporting Person was granted an option to purchase 152,064 shares of common stock of the Company. Options to purchase 38,016 shares vest on 8/24/21 and options to purchase 114,048 shares vest quarterly in 12 equal amounts commencing on 11/24/21.
  • [F7]On 12/14/21, the Reporting Person was granted an option to purchase 38,612 shares of common stock of the Company. Options to purchase 9,653 shares vest on 12/14/22 and options to purchase 28,959 shares vest quarterly in 12 equal amounts commencing on 3/14/23.

Documents

1 file

Issuer

NEPHROS INC

CIK 0001196298

→
Entity typeother

Related Parties

1
  • filerCIK 0001698052

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 9:16 PM ET
Size
16.3 KB
View on SEC.gov